DNAH14 and infection: Interestingly, removal of sialic acids from cell surface glycoconjugates by sialidase treatment somewhat enhanced the infection of MDCK II cells by chimeric VSV-HL18, as well as by recombinant HL17NL10 or HL18NL11 [18].